ÌÇÐÄvlog¹ÙÍø

Showing results 1 - 10 of 16
Medicare Part D does not allow plans to exclude drugs in six protected classes from their formularies, which may limit plans’ ability to…
A concerning number of hospitals have closed in the US in recent years and there are many other hospitals that are at significant risk of…
June 2023. GrowthPolicy’s Devjani Roy interviewed Soroush Saghafian, Associate Professor of Public Policy at Harvard Kennedy School and…
The US spends substantially more on health care per capita than other high-income countries yet leaves a greater share of the population…
Regulators of new products confront a tradeoff between speeding a new product to market and collecting additional product quality…
Importance: Germany’s unique approach to coverage determination and pricing has ensured that effective medicines remain on the market,…
Medicare Part D is an outpatient prescription drug benefit for older Americans covering more than 46 million beneficiaries. Except for…
Policy responses to the COVID-19 outbreak must strike a balance between maintaining essential supply chains and limiting the spread of the…